Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rothstein Kass was a premier national accounting, tax, and advisory firm that specialized in the financial services industry, particularly serving hedge funds, private equity, and venture capital. Founded in 1959, the firm grew to become one of the top accounting firms in the United States, known for its deep expertise in alternative investments. While the firm maintained a Life Sciences practice providing audit and tax services to biotech and healthcare companies, it was not a drug development or healthcare provider itself. In 2014, the firm was acquired by KPMG, which integrated Rothstein Kass's specialized professionals into its own Alternative Investment practice to strengthen its market position.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rothstein Kass.